COVID-19 Therapeutics for Nonhospitalized Patients


Rajesh T. Gandhi, MD1; Preeti N. Malani, MD, MSJ2,3; Carlos del Rio, MD4, JAMA. 2022;327(7):617-618. doi:10.1001/jama.2022.0335 Substantial progress has been made in therapeutics for nonhospitalized patients with COVID-19, but supply of and access to treatment remain limited. This Viewpoint…[...]

1 Million COVID Deaths: Here’s The Real Reason Why More People Died From COVID In The United States Than Every Other Country


Authors:  Alicia Powe May 14, 2022 Gateway Pundit After two years of inundating the public with propaganda and fear surrounding COVID-19, the mainstream media and the federal government turned the…[...]

The Epidemiology, Transmission, and Diagnosis of COVID-19


Authors: By: Neesha C. Siriwardane & Rodney Shackelford, DO, Ph.D. April 15, 2020 Introduction to COVID-19 Coronaviruses are enveloped single-stranded RNA viruses of the Coronaviridae family and order Nidovirales (1). The viruses are named for…[...]

NIH Clinical Trial Shows Remdesivir Accelerates Recovery from Advanced COVID-19


Authors: NIAID Office of Communications Hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than similar patients who received placebo, according to a preliminary data analysis…[...]